QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations

Understanding the interaction of ligands with biomolecules is an integral component of drug discovery and development. Challenges for computing thermodynamic and kinetic quantities for pharmaceutically relevant receptor-ligand complexes include the size and flexibility of the ligands, large-scale co...

Full description

Bibliographic Details
Main Authors: Ojha, Anupam Anand, Votapka, Lane, Amaro, Rommie
Format: Other/Unknown Material
Language:unknown
Published: American Chemical Society (ACS) 2023
Subjects:
Kon
Online Access:http://dx.doi.org/10.26434/chemrxiv-2023-s4n3r
https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/64d2d5bd69bfb8925a9adabf/original/q-mrebind-incorporating-quantum-mechanical-force-field-reparameterization-at-the-ligand-binding-site-for-improved-drug-target-kinetics-through-milestoning-simulations.pdf
id cracsoc:10.26434/chemrxiv-2023-s4n3r
record_format openpolar
spelling cracsoc:10.26434/chemrxiv-2023-s4n3r 2024-04-07T07:55:15+00:00 QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations Ojha, Anupam Anand Votapka, Lane Amaro, Rommie 2023 http://dx.doi.org/10.26434/chemrxiv-2023-s4n3r https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/64d2d5bd69bfb8925a9adabf/original/q-mrebind-incorporating-quantum-mechanical-force-field-reparameterization-at-the-ligand-binding-site-for-improved-drug-target-kinetics-through-milestoning-simulations.pdf unknown American Chemical Society (ACS) https://creativecommons.org/licenses/by/4.0/ posted-content 2023 cracsoc https://doi.org/10.26434/chemrxiv-2023-s4n3r 2024-03-08T00:17:37Z Understanding the interaction of ligands with biomolecules is an integral component of drug discovery and development. Challenges for computing thermodynamic and kinetic quantities for pharmaceutically relevant receptor-ligand complexes include the size and flexibility of the ligands, large-scale conformational rearrangements of the receptor, accurate force field parameters, simulation efficiency, and sufficient sampling associated with rare events. Our recently developed multiscale milestoning simulation approach, SEEKR2 (Simulation Enabled Estimation of Kinetic Rates v.2), has demonstrated success in predicting binding (kon) and unbinding (koff) kinetics by employing molecular dynamics (MD) simulations in regions closer to the binding site and Brownian dynamics (BD) simulations far from the binding site. The MD region is further subdivided into smaller Voronoi tessellations to improve the simulation efficiency and parallelization. To date, all MD simulations are run using general molecular mechanics (MM) force fields. The accuracy of calculations can be further improved by incorporating quantum mechanical (QM) methods into generating system-specific force fields through reparameterizing ligand charges in the bound state. The force field reparametrization process modifies the potential energy landscape of the bimolecular complex, enabling a more accurate representation of the intermolecular interactions and polarization effects at the bound state. We present QMrebind (Quantum Mechanical force field reparameterization at the receptor-ligand binding site), an ORCA-based software that facilitates reparameterizing the potential energy function within the phase space representing the bound state in a receptor-ligand complex. With existing data from our SEEKR2 estimates and experimentally determined kinetic rates, we compare and interpret the receptor-ligand unbinding kinetics obtained using the newly reparameterized force fields for model host-guest systems and HSP90-inhibitor complexes. This method provides an ... Other/Unknown Material Orca ACS Publications Kon ENVELOPE(161.092,161.092,55.397,55.397)
institution Open Polar
collection ACS Publications
op_collection_id cracsoc
language unknown
description Understanding the interaction of ligands with biomolecules is an integral component of drug discovery and development. Challenges for computing thermodynamic and kinetic quantities for pharmaceutically relevant receptor-ligand complexes include the size and flexibility of the ligands, large-scale conformational rearrangements of the receptor, accurate force field parameters, simulation efficiency, and sufficient sampling associated with rare events. Our recently developed multiscale milestoning simulation approach, SEEKR2 (Simulation Enabled Estimation of Kinetic Rates v.2), has demonstrated success in predicting binding (kon) and unbinding (koff) kinetics by employing molecular dynamics (MD) simulations in regions closer to the binding site and Brownian dynamics (BD) simulations far from the binding site. The MD region is further subdivided into smaller Voronoi tessellations to improve the simulation efficiency and parallelization. To date, all MD simulations are run using general molecular mechanics (MM) force fields. The accuracy of calculations can be further improved by incorporating quantum mechanical (QM) methods into generating system-specific force fields through reparameterizing ligand charges in the bound state. The force field reparametrization process modifies the potential energy landscape of the bimolecular complex, enabling a more accurate representation of the intermolecular interactions and polarization effects at the bound state. We present QMrebind (Quantum Mechanical force field reparameterization at the receptor-ligand binding site), an ORCA-based software that facilitates reparameterizing the potential energy function within the phase space representing the bound state in a receptor-ligand complex. With existing data from our SEEKR2 estimates and experimentally determined kinetic rates, we compare and interpret the receptor-ligand unbinding kinetics obtained using the newly reparameterized force fields for model host-guest systems and HSP90-inhibitor complexes. This method provides an ...
format Other/Unknown Material
author Ojha, Anupam Anand
Votapka, Lane
Amaro, Rommie
spellingShingle Ojha, Anupam Anand
Votapka, Lane
Amaro, Rommie
QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
author_facet Ojha, Anupam Anand
Votapka, Lane
Amaro, Rommie
author_sort Ojha, Anupam Anand
title QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
title_short QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
title_full QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
title_fullStr QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
title_full_unstemmed QMrebind: Incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
title_sort qmrebind: incorporating quantum mechanical force field reparameterization at the ligand binding site for improved drug-target kinetics through milestoning simulations
publisher American Chemical Society (ACS)
publishDate 2023
url http://dx.doi.org/10.26434/chemrxiv-2023-s4n3r
https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/64d2d5bd69bfb8925a9adabf/original/q-mrebind-incorporating-quantum-mechanical-force-field-reparameterization-at-the-ligand-binding-site-for-improved-drug-target-kinetics-through-milestoning-simulations.pdf
long_lat ENVELOPE(161.092,161.092,55.397,55.397)
geographic Kon
geographic_facet Kon
genre Orca
genre_facet Orca
op_rights https://creativecommons.org/licenses/by/4.0/
op_doi https://doi.org/10.26434/chemrxiv-2023-s4n3r
_version_ 1795672293120147456